Allison A. Feduccia

2.5k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Allison A. Feduccia is a scholar working on Clinical Psychology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Allison A. Feduccia has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Psychology, 11 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Allison A. Feduccia's work include Psychedelics and Drug Studies (11 papers), Cannabis and Cannabinoid Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Allison A. Feduccia is often cited by papers focused on Psychedelics and Drug Studies (11 papers), Cannabis and Cannabinoid Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). Allison A. Feduccia collaborates with scholars based in United States, Canada and Netherlands. Allison A. Feduccia's co-authors include Michael C. Mithoefer, Lisa Jerome, Amy Emerson, Berra Yazar‐Klosinski, Rick Doblin, Scott Hamilton, Julie Holland, Ann T. Mithoefer, Mark T. Wagner and Joy H. Wymer and has published in prestigious journals such as Scientific Reports, Journal of Affective Disorders and Psychopharmacology.

In The Last Decade

Allison A. Feduccia

16 papers receiving 1.1k citations

Hit Papers

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychot... 2018 2026 2020 2023 2018 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allison A. Feduccia United States 13 1.1k 435 387 370 185 16 1.2k
Amy Emerson United States 15 986 0.9× 411 0.9× 348 0.9× 368 1.0× 184 1.0× 23 1.1k
Ann T. Mithoefer United States 9 1.0k 1.0× 483 1.1× 313 0.8× 410 1.1× 253 1.4× 10 1.2k
Patrick Vizeli Switzerland 20 1.1k 1.0× 633 1.5× 531 1.4× 200 0.5× 267 1.4× 33 1.2k
Rafael Faria Sanches Brazil 15 1.2k 1.1× 556 1.3× 403 1.0× 496 1.3× 60 0.3× 25 1.7k
Nadia R. P. W. Hutten Netherlands 14 695 0.7× 424 1.0× 385 1.0× 167 0.5× 119 0.6× 25 868
Ben Sessa United Kingdom 17 918 0.9× 466 1.1× 369 1.0× 207 0.6× 134 0.7× 31 1.1k
Alicia Danforth United States 7 1.3k 1.2× 569 1.3× 722 1.9× 182 0.5× 108 0.6× 10 1.3k
Lisa Jerome United States 19 1.8k 1.7× 808 1.9× 583 1.5× 688 1.9× 463 2.5× 25 2.1k
Michael C. Mithoefer United States 18 1.9k 1.8× 812 1.9× 607 1.6× 682 1.8× 397 2.1× 29 2.1k
Berra Yazar‐Klosinski United States 18 1.9k 1.8× 913 2.1× 808 2.1× 591 1.6× 319 1.7× 28 2.2k

Countries citing papers authored by Allison A. Feduccia

Since Specialization
Citations

This map shows the geographic impact of Allison A. Feduccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison A. Feduccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison A. Feduccia more than expected).

Fields of papers citing papers by Allison A. Feduccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison A. Feduccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison A. Feduccia. The network helps show where Allison A. Feduccia may publish in the future.

Co-authorship network of co-authors of Allison A. Feduccia

This figure shows the co-authorship network connecting the top 25 collaborators of Allison A. Feduccia. A scholar is included among the top collaborators of Allison A. Feduccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison A. Feduccia. Allison A. Feduccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Feduccia, Allison A., et al.. (2023). The need for establishing best practices and gold standards in psychedelic medicine. Journal of Affective Disorders. 332. 47–54. 20 indexed citations
2.
Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2023). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. FOCUS The Journal of Lifelong Learning in Psychiatry. 21(3). 306–314. 6 indexed citations
3.
Price, Collin M., et al.. (2022). Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine–Assisted Therapy for Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology. 42(5). 464–469. 12 indexed citations
4.
Wang, Julie B., Jessica Lin, Allison R. Coker, et al.. (2021). Scaling Up: Multisite Open-Label Clinical Trials of MDMA-Assisted Therapy for Severe Posttraumatic Stress Disorder. Journal of Humanistic Psychology. 14 indexed citations
5.
Jerome, Lisa, et al.. (2021). Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder. Journal of Traumatic Stress. 34(4). 851–863. 33 indexed citations
6.
Greenway, Kyle T., Nicolas Garel, Lisa Jerome, & Allison A. Feduccia. (2020). Integrating psychotherapy and psychopharmacology: psychedelic-assisted psychotherapy and other combined treatments. Expert Review of Clinical Pharmacology. 13(6). 655–670. 59 indexed citations
7.
Monson, Candice M., Anne Catherine Wagner, Ann T. Mithoefer, et al.. (2020). MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial. European journal of psychotraumatology. 11(1). 1840123–1840123. 47 indexed citations
8.
Feduccia, Allison A., Lisa Jerome, Julie B. Wang, et al.. (2020). MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study. Scientific Reports. 10(1). 20442–20442. 88 indexed citations
9.
Gorman, Ingmar, Alexander Belser, Lisa Jerome, et al.. (2020). Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder. Journal of Traumatic Stress. 33(2). 161–170. 31 indexed citations
10.
Feduccia, Allison A., Lisa Jerome, Berra Yazar‐Klosinski, et al.. (2019). Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10. 650–650. 108 indexed citations
11.
Mithoefer, Michael C., et al.. (2019). S.08.06 MDMA-assisted psychotherapy for PTSD: A promising novel experimental treatment moving into phase 3 trials with FDA breakthrough therapy designation. European Neuropsychopharmacology. 29. S11–S12. 2 indexed citations
12.
Danforth, Alicia, Charles S. Grob, Allison A. Feduccia, et al.. (2018). Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology. 235(11). 3137–3148. 161 indexed citations
13.
Mithoefer, Michael C., Ann T. Mithoefer, Allison A. Feduccia, et al.. (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry. 5(6). 486–497. 272 indexed citations breakdown →
14.
G., Marcela Ot’alora, Jim Grigsby, Lisa Jerome, et al.. (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology. 32(12). 1295–1307. 155 indexed citations
15.
Feduccia, Allison A. & Michael C. Mithoefer. (2018). MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 84(Pt A). 221–228. 140 indexed citations
16.
Feduccia, Allison A., Julie Holland, & Michael C. Mithoefer. (2017). Progress and promise for the MDMA drug development program. Psychopharmacology. 235(2). 561–571. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026